Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Volume: 378, Issue: 21, Pages: 1976 - 1986
Published: May 24, 2018
Abstract
Antibodies that block programmed death 1 (PD-1) protein improve survival in patients with advanced non-small-cell lung cancer (NSCLC) but have not been tested in resectable NSCLC, a condition in which little progress has been made during the past decade.In this pilot study, we administered two preoperative doses of PD-1 inhibitor nivolumab in adults with untreated, surgically resectable early (stage I, II, or IIIA) NSCLC. Nivolumab (at a dose of...
Paper Details
Title
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Published Date
May 24, 2018
Volume
378
Issue
21
Pages
1976 - 1986
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History